This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Astrazeneca Ab. Active years: 2010-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Macclesfield, GB (2010)
- Alderley Park, GB (2012)
Company Filing History:
Years Active: 2010-2012
Title: David Alan Rudge: Innovator in Pharmaceutical Chemistry
Introduction
David Alan Rudge is a notable inventor based in Alderley Park, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding 2 patents that reflect his innovative work.
Latest Patents
His latest patents include advancements in phthalazinone derivatives. These compounds are characterized by a specific formula that includes various substituents and structural features, which are designed for therapeutic applications. The compounds he has developed are not only innovative but also have potential uses in pharmaceutical compositions.
Career Highlights
David works at AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to contribute to the development of new therapies that can improve patient outcomes. His expertise in chemistry and innovation has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
David has collaborated with notable colleagues, including Keith Allan Menear and Muhammad Hashim Javaid. These collaborations have likely enhanced the scope and impact of his research and inventions.
Conclusion
David Alan Rudge is a distinguished inventor whose work in pharmaceutical chemistry continues to influence the industry. His patents and collaborations reflect his commitment to innovation and improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile